EXAS vs SBUX · rev $2.76B vs P/E 76, rev $37.18B
EXACT Sciences Corporation (EXAS) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
EXAS currently screens at market cap $20.03B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the EXAS and SBUX stock pages for the full models.
Not investment advice.